# Intranasal Insulin for Weight Management During Smoking Cessation

> **NCT02028871** · PHASE2 · COMPLETED · sponsor: **Ajna Hamidovic** · enrollment: 26 (actual)

## Conditions studied

- Tobacco Abstinence Syndrome

## Interventions

- **DRUG:** Intranasal Insulin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02028871
- **Lead sponsor:** Ajna Hamidovic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2018-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02028871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02028871, "Intranasal Insulin for Weight Management During Smoking Cessation". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02028871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*